Ideaya Biosciences Is A Clinical Stage Precision Medicine Oncology Company Based In South San Franciscocaliforniathe Company Specializes In Discovering And Developing Targeted Therapeutics For Cancer Patients Identified Through Molecular Diagnosticsideaya Employs The Concept Of Synthetic Lethalitywhich Focuses On Exploiting Genetic Vulnerabilities In Cancer Cells To Create Treatments That Selectively Kill These Cells While Preserving Normal Cells The Company S Pipeline Includes Several Clinical Stage Compoundssuch As Darovasertibide196 A Pkc Inhibitor For Tumors With Gnaq Or Gna11 Mutationside397A Mat2A Inhibitor For Tumors With Mtap Gene Deletionand Ide161A Parg Inhibitor For Tumors With Homologous Recombination Deficiencyideaya Collaborates With Major Pharmaceutical Companies Like Pfizeramgenand Glaxosmithkline To Enhance Its Research And Development Efforts In Precision Medicinethe Leadership Teamled By President And Ceo Yujiro Shataincludes Experts In Cancer Biology And Drug Discovery
